Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)
1 clinical trials · Condition
◉ Watch Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)
| Record | Firm | Date |
|---|---|---|
| Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study) (NCT03570281) | Samsung Medical Center | 2018-06-15 |
Track Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban) automatically
Every clearance here is in the API, with alerts when new ones post.